clinical trials

French biotech firm Abivax lost over 40% of its market value after a clinical trial revealed cancer cases in its bowel disease drug study, derailing a potential takeover. Adverse trial data can rapidly destroy deal certainty and investor confidence in clinical-stage assets.

Isomorphic Labs, a DeepMind spinoff, has built a pipeline of AI-designed medicines headed to human trials. This milestone represents the first major transition of AI-discovered drugs from laboratory to clinical testing, potentially accelerating pharmaceutical development timelines.

Zealand's stock plummeted 35% after their joint drug with Roche showed disappointing 10.7% weight loss results in mid-stage trials. CEO downplays competitive comparisons amid intense competition in the weight-loss drug market.